Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Diffuse large b-cell lymphoma recurrent: Which Medications Cause It? (1,802 Reports Across 81 Drugs)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Diffuse large b-cell lymphoma recurrent has been reported as an adverse event with 81 different drugs in the FDA's FAERS database, with 1,802 total reports. 353 of these reports resulted in death.The drugs most commonly associated with Diffuse large b-cell lymphoma recurrent are RITUXIMAB, CYCLOPHOSPHAMIDE, and VINCRISTINE.

1,802
Total Reports
81
Drugs Involved
353
Deaths
274
Hospitalizations
62.9 yrs
Average Patient Age
43.0% / 57.0%
Female / Male

Which Drugs Cause Diffuse large b-cell lymphoma recurrent Most Often?

Drug Reports % of Drug Reports Deaths Hosp. Life-Threat.
RITUXIMAB 1,359 0.8% 171 203 94
CYCLOPHOSPHAMIDE 1,007 0.8% 145 165 74
VINCRISTINE 957 1.3% 137 162 74
DOXORUBICIN 953 1.2% 138 157 70
PREDNISONE 738 0.5% 123 127 64
CYTARABINE 406 0.9% 104 67 20
DEXAMETHASONE 402 0.3% 85 52 22
ETOPOSIDE 375 0.7% 61 70 19
CISPLATIN 306 0.6% 46 47 20
GEMCITABINE 280 0.9% 22 35 12
BENDAMUSTINE 255 1.3% 71 54 15
PREDNISOLONE 247 0.3% 26 35 9
IFOSFAMIDE 232 1.4% 47 52 13
METHOTREXATE 221 0.1% 62 38 21
CARBOPLATIN 217 0.3% 38 44 13
TISAGENLECLEUCEL 200 4.7% 109 25 27
OXALIPLATIN 189 0.3% 13 19 2
POLATUZUMAB VEDOTIN 177 3.7% 32 49 14
LENALIDOMIDE 105 0.0% 17 10 2
POLATUZUMAB VEDOTIN-PIIQ 81 2.6% 7 5 0

View all 81 drugs →

Top 3 Drugs Associated With Diffuse large b-cell lymphoma recurrent

1,359 reports
1,007 reports
957 reports

Related Side Effects

Drug ineffective (1,049,718) Off label use (762,782) Death (660,423) Fatigue (599,248) Nausea (562,301) Diarrhoea (491,550) Pain (471,975) Headache (460,069) Dyspnoea (409,496) Dizziness (352,922)